- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
54
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
54 companies
Everest Medicines
Market Cap: HK$18.8b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$53.20
7D
-5.8%
1Y
109.0%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥31.1b
Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.
688192
CN¥67.78
7D
-6.4%
1Y
63.3%
Alnylam Pharmaceuticals
Market Cap: US$60.4b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$460.46
7D
0.9%
1Y
62.0%
Cynata Therapeutics
Market Cap: AU$54.6m
Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.
CYP
AU$0.23
7D
2.2%
1Y
-4.2%
Takara Bio
Market Cap: JP¥116.2b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥965.00
7D
1.3%
1Y
-8.5%
AstraZeneca
Market Cap: UK£198.2b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£127.82
7D
1.0%
1Y
8.7%
AbbVie
Market Cap: US$407.2b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$230.50
7D
-1.5%
1Y
18.7%
Kuros Biosciences
Market Cap: CHF 1.1b
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 29.00
7D
1.8%
1Y
46.3%
Cantourage Group
Market Cap: €37.4m
Operates as a medical cannabis company in Europe.
HIGH
€3.00
7D
-17.8%
1Y
-40.6%
SK Biopharmaceuticals
Market Cap: ₩8.1t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩103,900.00
7D
-0.1%
1Y
-11.8%
Bonesupport Holding
Market Cap: SEK 16.9b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 256.40
7D
-15.0%
1Y
-23.1%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥12.6b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥18.19
7D
2.2%
1Y
22.5%
Rhythm Pharmaceuticals
Market Cap: US$6.7b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$100.82
7D
1.8%
1Y
102.4%
Galderma Group
Market Cap: CHF 33.9b
Operates as a dermatology company worldwide.
GALD
CHF 142.90
7D
2.1%
1Y
79.7%
Hanall Biopharma
Market Cap: ₩1.8t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩34,950.00
7D
1.3%
1Y
-19.4%
Immutep
Market Cap: AU$448.9m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.30
7D
10.9%
1Y
-4.7%
PharmaResearch
Market Cap: ₩5.6t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩542,000.00
7D
-1.5%
1Y
155.7%
Ligand Pharmaceuticals
Market Cap: US$3.5b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$177.73
7D
-1.8%
1Y
72.7%
Caris Life Sciences
Market Cap: US$8.6b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$30.48
7D
-4.1%
1Y
n/a
BioGaia
Market Cap: SEK 10.8b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 106.40
7D
-2.3%
1Y
-0.6%
BioLife Solutions
Market Cap: US$1.3b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$26.80
7D
0.8%
1Y
18.6%
Vitrolife
Market Cap: SEK 18.6b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 137.00
7D
-0.07%
1Y
-42.6%
Akeso
Market Cap: HK$117.9b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$128.00
7D
-8.4%
1Y
98.4%
Biocon
Market Cap: ₹471.7b
Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.
BIOCON
₹353.45
7D
0.3%
1Y
2.1%
Shanghai OPM Biosciences
Market Cap: CN¥6.9b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥61.00
7D
-5.0%
1Y
89.3%
Daiichi Sankyo Company
Market Cap: JP¥7.5t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥4,064.00
7D
9.0%
1Y
-18.4%
Valneva
Market Cap: €776.9m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLA
€4.52
7D
-9.1%
1Y
80.1%
Sotera Health
Market Cap: US$4.4b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$15.35
7D
-3.8%
1Y
0.2%
Simcere Pharmaceutical Group
Market Cap: HK$32.4b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$12.49
7D
-5.2%
1Y
89.2%
AprilBioLtd
Market Cap: ₩775.2b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩34,350.00
7D
12.1%
1Y
41.4%
Genovis AB (publ.)
Market Cap: SEK 1.4b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 21.00
7D
-12.3%
1Y
-11.4%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$113.9b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$488.60
7D
-13.0%
1Y
153.3%
Diaceutics
Market Cap: UK£137.1m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.62
7D
-1.8%
1Y
21.8%
Indoco Remedies
Market Cap: ₹26.5b
Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.
INDOCO
₹287.30
7D
-1.1%
1Y
-14.8%
Eli Lilly
Market Cap: US$748.3b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$833.49
7D
-0.8%
1Y
-10.6%
InnoCare Pharma
Market Cap: HK$29.1b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$14.71
7D
-22.2%
1Y
113.2%